Qube Research & Technologies Ltd

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1729829 LONDON, X0

Position in PRAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$51,047,105

+$9,733,326 QoQ

Shares Held

152,475

+18.9% QoQ

Ownership

0.546%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#39

of 308 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. PRAX ranks #14 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,047,105	152,475	+18.9%	Shares	Sole	2026-08-14
2026-03-31	$41,313,779	128,228	-24.1%	Shares	Sole	2026-05-15
2025-12-31	$49,780,701	168,897	+194.7%	Shares	Sole	2026-02-17
2025-09-30	$3,037,112	57,304	+79.1%	Shares	Sole	2025-11-14
2024-12-31	$2,462,643	31,999	-28.4%	Shares	Sole	2025-02-14
2024-09-30	$2,572,210	44,703	-50.7%	Shares	Sole	2024-11-14
2024-06-30	$3,751,061	90,693	-31.8%	Shares	Sole	2024-08-14
2024-03-31	$8,112,120	132,942	+429.6%	Shares	Sole	2024-05-14
2023-12-31	$559,317	25,104	+7484.3%	Shares	Sole	2024-02-13
2023-09-30	$566	331	-99.6%	Shares	Sole	2023-11-13
2023-06-30	$87,103	75,742	+118.1%	Shares	Sole	2023-08-14
2022-09-30	$78,832	34,728	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.